| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 3871969 | The Journal of Urology | 2009 | 7 Pages |
Abstract
Evidence for a favorable impact of platelet derived growth factor receptor inhibitor therapy on the efficacy of neoadjuvant docetaxel and hormonal ablation in high risk localized prostate cancer was not obtained.
Keywords
Related Topics
Health Sciences
Medicine and Dentistry
Nephrology
Authors
Paul Mathew, Louis L. Pisters, Christopher G. Wood, John N. Papadopoulos, Dallas L. Williams, Peter F. Thall, Sijin Wen, Erin Horne, Carol J. Oborn, Robert Langley, Isaiah J. Fidler, Curtis A. Pettaway,